ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,648Medicare Part D Prescriptions Filled, Including Refills

Rank: 1454 out of 5176

$689K Total Retail Price of All Prescriptions

Rank: 637 out of 5176

249 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 249 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 6,065 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

54% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$104 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
CRESTOR 257 229 1 15
LOVAZA 225 194 2 43
NEXIUM 221 189 3 16
AMLODIPINE BESYLATE 164 162 4 2
TAMSULOSIN HCL 136 135 5 20
CARVEDILOL 132 132 6 24
LIDODERM 131 123 7 59
LOSARTAN POTASSIUM 129 121 8 14
METOPROLOL SUCCINATE 124 123 9 11
GABAPENTIN 114 107 10 21
FUROSEMIDE 107 100 11 8
LOSARTAN-HYDROCHLOROTHIAZIDE 107 90 11 35
ATORVASTATIN CALCIUM 100 95 13 9
ATENOLOL 95 83 14 12
CALCITONIN-SALMON 94 92 15 293
SIMVASTATIN 90 84 16 1
PLAVIX 89 89 17 29
ADVAIR DISKUS 81 74 18 32
SOLARAZE 80 75 19 157
JANUMET 79 64 20 77
BENICAR HCT 74 71 21 110
ZOLPIDEM TARTRATE 70 70 22 17
METFORMIN HCL 69 61 23 7
ENALAPRIL MALEATE 65 54 24 22
VOLTAREN 63 61 25 97
DIOVAN 62 62 26 19
METOPROLOL TARTRATE 62 44 26 6
DIOVAN HCT 62 53 26 39
NAMENDA 60 60 29 47
RAMIPRIL 60 59 29 50
CLOPIDOGREL 59 59 31 26
ZETIA 58 53 32 68
JANUVIA 56 43 33 25
CHLORHEXIDINE GLUCONATE 54 50 34 202
SYNTHROID 52 51 35 33
RANITIDINE HCL 50 48 36 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 2, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.